Home > Threshold Pharmaceuticals Salary

Threshold Pharmaceuticals Salary

  • 27
  • 31
  • 59
Threshold Pharmaceuticals average salary is $225,490, median salary is $225,490 with a salary range from $51,979 to $399,000.
Threshold Pharmaceuticals salaries are collected from government agencies and companies. Each salary is associated with a real job position. Threshold Pharmaceuticals salary statistics is not exclusive and is for reference only. They are presented "as is" and updated regularly.
Total 2 Threshold Pharmaceuticals Salaries. Sorted by Date, page 1
Ranked By:
Job Title Salaries City Year More info
Graphic Designer 399,000-399,000 Houston, TX, 77001 2014 Threshold Pharmaceuticals Graphic Designer Salaries (1)
Threshold Pharmaceuticals Houston, TX Salaries
Technical Analyst 51,979-51,979 Houston, TX, 77001 2012 Threshold Pharmaceuticals Technical Analyst Salaries (1)
Threshold Pharmaceuticals Houston, TX Salaries
Calculate how much you could earn

It's FREE. Based on your input and our analysis.     How we do it?

All fields are required for calculation accuracy.

  • We will send you an email to access your personalized report.
  • We won’t share your email address

Threshold Pharmaceuticals salary is full-time annual starting salary. Intern, contractor and hourly pay scale vary from regular exempt employee. Compensation depends on work experience, job location, bonus, benefits and other factors.

Real Jobs Salary - Salary List
Calculate Your Salary Ranking
Threshold Pharmaceuticals Jobs
See more Threshold Pharmaceuticals Jobs»
Search All Jobs

JobCompare – Find open jobs faster
Threshold Pharmaceutic... Information
  • Threshold Pharmaceuticals, Inc
  • Industry: BioTech/Drugs
  • City: Redwood City, CA
  • Threshold Pharmaceuticals was founded in 2001 with the goal of improving cancer treatment and diagnosis. We are developing cancer therapies that selectively target cancer cells while relatively sparing normal cells. Our approach is to use our expertise in conjugation chemistry to rationally design compounds that take advantage of the metabolic abnormalities of cancer cells. These novel conjugate compounds selectively accumulate in malignant cells and subsequently destroy them while relatively sparing normal cells.